CXCL9 and Kawasaki disease: CXCL9 has been increasingly reported as a key biomarker in MIS-C due to its role in macrophage activation and Th1-driven cytokine responses, with several studies highlighting its discriminative value compared to other febrile inflammatory syndromes such as Kawasaki disease [8].